(Health-NewsWire.Net, June 26, 2019 ) Breast Imaging Technologies Market growth is largely driven by factors such as technological advancements, the rising prevalence of breast cancer, the increasing number of screening programs as well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis. The emerging markets, growing government and private investments to meet the increasing demand for breast cancer screening, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.
Based on technology, the global breast imaging industry is segmented into ionizing breast imaging, non-ionizing breast imaging, and other breast imaging technologies. The non-ionizing breast imaging segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the advantages offered by non-ionizing breast imaging technologies over ionizing breast imaging technologies, such as greater generation of anatomical details for diagnosis, high sensitivity to small breast lesions in women with dense breast tissues, and fewer false positives.
Download PDF - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897
The market for ionizing breast imaging technologies, by type, comprises mammography (analog mammography, full-field digital mammography, and 3D breast tomosynthesis), positron emission tomography-computed tomography (PET-CT), molecular breast imaging (MBI), and positron emission mammography (PEM). Mammography accounted for the largest share of the ionizing breast imaging technologies market in 2018. Its large share can be attributed to technological advancements in this segment and increasing awareness.
The Asia Pacific is one of the major revenue-generating regions in the breast imaging market. China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries focusing on the improvement of breast health. Furthermore, the increasing geriatric population and the growing incidence of breast cancer are also driving the growth of this regional market.
Key Market Players Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), and Philips Healthcare (Netherlands) dominated the breast imaging market. Other players in this market include Fujifilm Holdings Corporation (Japan), Aurora Imaging Technology, Inc. (US), Canon Inc. (Japan), CMR Naviscan Corporation (US), Delphinus Medical Technologies, Inc. (US), Dilon Technologies, Inc. (US), KUB Technologies Inc. (Kubtec) (US), Micrima Limited (UK), Planmed Oy (Finland), SonoCiné, Inc. (US), and SuperSonic Imagine (France), among others.
Know more about Breast Imaging Market - https://www.marketsandmarkets.com/PressReleases/breast-imaging-technologies.asp
MarketsandMarkets™
Mr. Shelly Singh
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com
|